Frequently Asked Questions

Syntro Health is an AI-powered precision clinical nutrition platform that translates medical nutrition therapy (MNT), the Harvard Healthy Eating Plate, and ICMR-NIN 2020 guidelines into personalized 7-day cellular diet protocols. It assesses 20+ health biomarkers, clinical conditions, active medications, and regional cuisine preferences, calculating exact daily energy via Mifflin-St Jeor and applying 30+ deterministic safety checks before delivering meal plans.

Cellular nutrition moves beyond simple caloric arithmetic by optimizing the quality, timing, and molecular signaling of nutrients. It focuses on essential amino acid pacing (reaching the 2.5–3.0g leucine threshold to activate mTORC1 muscle protein synthesis), glycemic load capping (<80 GL/day to prevent insulin spikes), bioactive fatty acid ratios (maintaining omega-6 to omega-3 between 3:1 and 5:1), and micronutrient bioavailability, mitigating cellular oxidative stress and chronic inflammation.

Syntro Health operates a dual-architecture system: all mathematical energy targets, macronutrient distributions, electrolyte caps, and drug-nutrient contraindications are computed deterministically in Python using validated clinical equations. The generative AI is only used to assemble culturally authentic recipes strictly within these non-negotiable mathematical guardrails, ensuring that no AI hallucination can ever violate clinical safety thresholds.

Syntro Health synthesizes evidence from the Harvard T.H. Chan School of Public Health Healthy Eating Plate, Maurice Shils' Modern Nutrition in Health and Disease (11th Ed.), Krause's Food & The Nutrition Care Process (15th Ed.), ICMR-NIN 2020 Recommended Dietary Allowances for Indians, the Indian Food Composition Tables (IFCT 2017), KDIGO 2024 renal nutrition standards, ADA 2026 diabetes protocols, and ACC/AHA cardiovascular guidelines.

The Quick Intake (/quick-questionnaire) is a rapid 60-second screening that collects core biometrics (age, sex, height, weight, activity, primary goal, and cuisine style) to compute immediate baseline caloric and macronutrient requirements. The Comprehensive Analysis (/questionnaire) evaluates 20+ longitudinal biomarkers (HbA1c, fasting glucose, eGFR, lipid panel, BP), detailed medical history, active medications, allergies, and symptom profiles for full clinical MNT.

Yes. For Type 2 Diabetes, Syntro Health caps daily glycemic load at <80 GL, eliminates refined carbohydrates (maida) and simple sugars, and pairs every carbohydrate serving with soluble fiber, protein, and healthy fats. Caloric distribution is calibrated against HbA1c and fasting blood sugar, and pharmacological safeguards automatically monitor Metformin interactions with Vitamin B12 absorption.

For CKD Stages 3–4 (non-dialysis), Syntro Health restricts protein to 0.6–0.8 g/kg dry body weight with at least 50% High Biological Value (HBV) protein to prevent uremic toxicity. Potassium and phosphorus are monitored and capped per KDIGO guidelines, and culinary leaching protocols are provided. Hemodialysis and End-Stage Renal Disease (Stage 5) are hard-gated with mandatory human clinical referral notices.

Syntro Health applies an adapted Indian DASH protocol: dietary sodium is strictly capped at <1,500–2,000 mg/day (<3.75g NaCl), while natural dietary potassium (≥3,500–4,700 mg/day) and magnesium (≥400 mg/day) are boosted through tender coconut water, leafy greens, pulses, and seeds. The system forbids potassium chloride salt substitutes if the user is concurrently prescribed ACE inhibitors or ARBs.

Our PCOS protocol targets upstream hyperinsulinemia to reduce ovarian theca cell androgen production. We enforce a low-glycemic load (<70 GL/day), 1.2–1.4 g/kg protein, and high dietary fiber (≥35g/day) to upregulate Sex Hormone-Binding Globulin (SHBG). The diet incorporates spearmint tea, ground flaxseed lignans, Ceylon cinnamon, and dietary inositol precursors to restore hormonal equilibrium and ovulatory regularity.

For underactive thyroid, Syntro creates a strict 60-minute post-waking window where Levothyroxine is taken fasting with water, completely separated from calcium, iron, soy, and walnuts. The meal plan supplies 100–200 mcg selenium (via Brazil nuts), zinc, and tyrosine to optimize peripheral T4-to-T3 deiodinase enzyme conversion, while mandating that all cruciferous vegetables are cooked to denature goitrogens.

Syntro Health implements the Portfolio Diet and ACC/AHA guidelines: saturated fatty acids are restricted to <7% of daily calories, industrial trans fats are eliminated (0g), and viscous soluble fiber is elevated to ≥15–20 g/day (using oats beta-glucan and psyllium husk). Monounsaturated fats (MUFA, 15–20%) from cold-pressed mustard or olive oil replace saturated fats to upregulate hepatic LDL receptor clearance.

Syntro Health checks a deterministic library of 30+ pharmacological interaction rules during recipe formulation. Examples include blocking grapefruit and Seville oranges for statin users (CYP3A4 inhibition), enforcing day-to-day Vitamin K consistency for Warfarin users, separating calcium and iron from Levothyroxine, and prohibiting potassium supplements with ACE inhibitors.

Grapefruit and Seville oranges contain furanocoumarins that irreversibly inhibit intestinal cytochrome P450 3A4 (CYP3A4) enzymes. Because statins like Atorvastatin and Simvastatin are normally metabolized by CYP3A4, inhibiting this enzyme can increase systemic statin bioavailability by up to 300–500%, drastically elevating the risk of hepatic toxicity and fatal rhabdomyolysis (muscle breakdown).

Levothyroxine requires an acidic gastric environment for optimal absorption. Ingesting it with food, coffee, milk, or calcium/iron supplements causes insoluble chelate formation that decreases drug absorption by over 50%. Syntro's schedule mandates taking Levothyroxine upon waking with plain water, delaying breakfast by 45–60 minutes, and spacing mineral supplements by at least 4 hours.

ACE inhibitors (Ramipril, Enalapril) and ARBs (Telmisartan, Losartan) suppress aldosterone synthesis, diminishing renal potassium excretion. Syntro Health strictly forbids potassium chloride 'light' or 'diet' salt substitutes and limits acute potassium surges from concentrated supplements to prevent hyperkalemia-induced cardiac conduction abnormalities.

Syntro Health enforces hard clinical safety gates for: End-Stage Renal Disease on Hemodialysis or Peritoneal Dialysis, active pregnancy or lactation, active eating disorders (SCOFF score ≥2 or BMI <16), acute decompensated liver cirrhosis, acute pancreatitis, and severe active oncology treatment. For these profiles, automated plan generation is disabled until explicit physician clearance is documented.

Yes, absolutely. Syntro Health has deep native support for Indian lacto-vegetarian, lacto-ovo vegetarian, and 100% plant-based vegan patterns. Our protein engine strategically pairs complementary plant proteins (e.g. cereals + pulses, moong + rice, soya chunks + whole grains) to guarantee complete essential amino acid profiles and leucine trigger thresholds.

Syntro Health supports four primary regional Indian culinary traditions: North Indian (roti, dal makhani alternatives, paneer, seasonal sabzis), South Indian (idli, dosa, sambar, rasam, poriyal), West Indian (Gujarati and Maharashtrian preparations with balanced sweetness and spices), and East Indian (fish curries, mustard-based preparations, postor sabzi).

Grains are generally limited in lysine but adequate in methionine, while legumes are rich in lysine but limited in methionine. Syntro's meal pairing engine combines legumes and grains in exact clinical ratios, while incorporating high-yield foods like defatted soya chunks (52% protein), low-fat paneer, Greek yogurt, seeds, and nuts to ensure every meal achieves amino acid completeness.

Yes, when prepared and portioned properly. While polished white rice and maida cause rapid glucose spikes, traditional whole grains like jowar, bajra, ragi, and unpolished brown or parboiled rice have favorable glycemic profiles. When combined with double portions of fiber-rich dal and green vegetables, traditional Indian meals deliver outstanding metabolic stability.

Syntro Health can adapt meal timing into 16:8 or 14:10 time-restricted feeding windows. However, the system actively disallows fasting for individuals taking exogenous insulin or sulfonylureas (due to lethal hypoglycemia risks), individuals with a history of disordered eating, or pregnant women.

Syntro Health uses an intelligent Vision and Document Processing pipeline to extract biomarkers (HbA1c, fasting glucose, serum creatinine, eGFR, lipid profile, liver enzymes, electrolytes) from PDF or image lab reports. All extracted values are verified through confidence scoring before updating the user's clinical profile.

Yes. Syntro Health adheres to strict data privacy principles aligned with HIPAA and Indian digital health data guidelines. Health metrics and lab reports are encrypted in transit via TLS 1.3 and encrypted at rest with AES-256. User health records are never sold, rented, or shared with third-party advertisers or insurance brokers.

No. Syntro Health is an evidence-based clinical decision support and nutritional planning platform, not a diagnostic medical device. It does not diagnose diseases or prescribe pharmaceutical medications. Users are advised to review all dietary protocols with their attending physician or registered dietitian.

Yes. Syntro Health includes a dedicated Professional Portal where doctors, registered dietitians, and fitness coaches can manage multiple patient profiles, review automated clinical contraindication audits, customize macro thresholds, and export white-labeled 7-day clinical meal protocols.

We recommend updating your plan whenever your biomarkers change—typically every 8 to 12 weeks following repeat HbA1c, lipid, or renal function panels—or whenever body weight shifts by more than 3 to 5 kilograms, ensuring that energy calculations and protein targets remain precisely calibrated.